AGILENT TECHNOLOGIES, INC. (A) FY2026 Q3 P&L / Income Statement

AGILENT TECHNOLOGIES, INC. (A) FY2026 Q3 P&L / Income Statement

Income statement for 2026-05-01 through 2026-07-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net revenue

1,878,000,000 US dollars

Total cost of revenue (calculated)

836,000,000 US dollars

Gross profit (calculated)

1,042,000,000 US dollars

Operating expenses (calculated)

598,000,000 US dollars

Income from operations

444,000,000 US dollars

Other income (expense), net (calculated)

0 US dollars

Income before taxes

444,000,000 US dollars

Provision for income taxes

82,000,000 US dollars

Net income

362,000,000 US dollars

Life Sciences and Diagnostics Markets

746,000,000 US dollars

Agilent CrossLab

786,000,000 US dollars

Applied Markets

346,000,000 US dollars

Cost of revenue

836,000,000 US dollars

Research and development

123,000,000 US dollars

Selling, general and administrative

475,000,000 US dollars

Life Sciences and Diagnostics Markets costs (calculated)

570,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Agilent CrossLab costs (calculated)

516,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Applied Markets costs (calculated)

260,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Reconciling items (calculated)

88,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.